Table 2.
Expected remaining lifetime (years) by age, sex, and treatment modality of prevalent dialysis patients, prevalent transplant patients, and the general U.S. population (2012) based on USRDS data and the National Vital Statistics Reporta
| ESRD patients, 2013 | General U.S. population, 2012 | |||||
|---|---|---|---|---|---|---|
| Dialysis | Transplant | Male | Female | |||
| Age | Male | Female | Male | Female | ||
| 0–14 | 24.1 | 22.4 | 59.2 | 61.2 | 70.7 | 75.4 |
| 15–19 | 20.9 | 19.3 | 46.8 | 48.6 | 59.7 | 64.4 |
| 20–24 | 18.1 | 16.5 | 42.5 | 44.2 | 55.0 | 59.5 |
| 25–29 | 15.8 | 14.3 | 38.6 | 40.2 | 50.3 | 54.6 |
| 30–34 | 14.1 | 13.0 | 34.7 | 36.4 | 45.7 | 49.7 |
| 35–39 | 12.5 | 11.7 | 30.8 | 32.4 | 41.0 | 45.0 |
| 40–44 | 10.8 | 10.3 | 26.9 | 28.6 | 36.4 | 40.3 |
| 45–49 | 9.1 | 8.8 | 23.2 | 24.8 | 31.9 | 35.6 |
| 50–54 | 7.7 | 7.7 | 19.8 | 21.3 | 27.7 | 31.1 |
| 55–59 | 6.5 | 6.6 | 16.6 | 18.1 | 23.7 | 26.8 |
| 60–64 | 5.5 | 5.7 | 13.8 | 15.2 | 19.8 | 22.6 |
| 65–69 | 4.5 | 4.8 | 11.4 | 12.7 | 16.2 | 18.5 |
| 70–74 | 3.8 | 4.0 | 9.4 | 10.4 | 12.8 | 14.7 |
| 75–79 | 3.2 | 3.5 | 7.7b | 8.6b | 9.8 | 11.3 |
| 80–84 | 2.6 | 2.9 | 7.1 | 8.4 | ||
| 85+ | 2.1 | 2.4 | 7.9 | 5.8 | ||
The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. government
ESRD, End-stage renal disease
aData Sources are Table H.13 in the 2015 USRDS annual data report [12], special analyses in the USRDS United States Renal Data System database, National Vital Statistics Report (2013, vol 2, chapter 6, Table 6.4). Table 7 . Life expectancy at selected ages, by race, Hispanic origin, race for non-Hispanic population, and sex: United States, 2012 (2015). Expected remaining lifetimes (years) of the general U.S. population and of period prevalent dialysis and transplant patients
bCell values combine ages 75+